Patents-Review.com
ClassID:

93257 ⎘

C07C279/28 - CPC Classification

Classification description:

Derivatives of guanidine, i.e. compounds containing the group , the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides

Recent Application in this class:
#1
20260078082
2026-03-19

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

 #2
20250228777
2025-07-17

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

 #3
20250145760
2025-05-08

EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT

 #4
20240409504
2024-12-12

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

 #5
20240124388
2024-04-18

Compounds and compositions for intracellular delivery of therapeutic agents

 #6
20230233551
2023-07-27

COMPOSITIONS AND METHODS FOR TREATMENT

 #7
20220409536
2022-12-29

Compounds and compositions for intracellular delivery of therapeutic agents

 #8
20220380299
2022-12-01

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

 #9
20220204457
2022-06-30

ARGININE GINGIPAIN INHIBITORS

 #10
20220106265
2022-04-07

Compositions and methods for the treatment of cancer

 #11
20210171455
2021-06-10

Alpha-5 beta-1 inhibitors

 #12
20200199067
2020-06-25

Hydrogen sulfide donor in organic salt form and preparation method therefor

 #13
20200171158
2020-06-04

PRESERVED COMPOSITIONS CONTAINING HYALURONIC ACID OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF AND RELATED METHODS

 #14
20200123100
2020-04-23

Compounds and compositions for intracellular delivery of therapeutic agents

 #15
20190076534
2019-03-14

Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods

 #16
20190016669
2019-01-17

Compounds and compositions for intracellular delivery of therapeutic agents

 #17
20180273467
2018-09-27

Compounds and compositions for intracellular delivery of therapeutic agents

 #18
20180201572
2018-07-19

Compounds and compositions for intracellular delivery of therapeutic agents

 #19
20180171135
2018-06-21

INTERLAYER INSULATING RESIN FILM, INTERLAYER INSULATING RESIN FILM HAVING ADHESIVE AUXILIARY LAYER, AND PRINTED CIRCUIT BOARD

 #20
20170305807
2017-10-26

Solvent for thiophosphoric triamide or dicyandiamide solutions, and related methods

 #21
20170210698
2017-07-27

Compounds and compositions for intracellular delivery of therapeutic agents

 #22
20170210697
2017-07-27

Compounds and compositions for intracellular delivery of therapeutic agents

 #23
20150140082
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

 #24
20140161872
2014-06-12

Compositions and methods for treatment

 #25
20120232019
2012-09-13

Compositions and methods for treatment of eye disorders

 #26
20110165229
2011-07-07

Compositions and methods for treatment

 #27
20110165228
2011-07-07

Compositions and methods for treatment

 #28
20100092542
2010-04-15

Compositions and methods for treatment of eye disorders

 #29
20100092541
2010-04-15

COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS

 #30
20080255230
2008-10-16

Therapeutic fluoroethylcyano guanidines

 #31
20080064717
2008-03-13

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

 #32
20080032981
2008-02-07

ARYL N-CYANOGUANIDINES AND METHODS RELATED THERETO

 #33
20070142333
2007-06-21

CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION

 #34
20060281739
2006-12-14

Compositions and methods for treatment of eye disorders

 #35
20050234106
2005-10-20

Cycloalkyl inhibitors of potassium channel function

 #36
20050182057
2005-08-18

Aryl N-cyanoguanidines and methods related thereto

 #37
20050119245
2005-06-02

GlyT2 modulators